Shalina is proud to announce the inauguration of its new ointment manufacturing facility on 3rd October 2016 at its plant in Pune, India. The state-of-the-art ointment manufacturing facility along with a dedicated warehousing block will enhance our monthly production capacity of creams to 13 million tubes and lotions to 3 million bottles. This expansion was undertaken with a capital investment of 4 million USD.
The facility is conceptualized and designed along the WHO cGMP guidelines leading to easy and efficient material handling from raw materials to finished goods. It is a fully automated, closed manufacturing concept so that the finished product made is with minimal human intervention. The facility is supported by the world class quality testing lab having the latest QA and QC instrumentation.
Our vision to provide affordable medicines available across Africa has guided our strategic capacity enhancement initiatives throughout the last 3 decades of existence. With this strategic initiative, Shalina will continue to be a leader in the healthcare industry in Africa.
